Interventions for nail psoriasis (Q24201549)

3

0 references

author name string

Anna Christa Q de Vries

1

0 references

Nathalie A Bogaards

2

0 references

Marieke Velema

4

0 references

Marcel Pasch

5

0 references

Mark Lebwohl

6

0 references

Phyllis I Spuls

Cochrane Database of Systematic Reviews

7

0 references

publication date

31 January 2013

0 references

published in

0 references

cites work

Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Improvement of psoriatic onychodystrophy by a water-soluble nail lacquer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Allopurinol in psoriasis--a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Management of nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Management of psoriatic nail disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Quality of life in patients with psoriasis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Nail psoriasis and biologics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Modification of the Nail Psoriasis Severity Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Approach to managing patients with nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Epidemiology of psoriasis. Review and the German perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

Antigens from Leishmania amastigotes induced clinical remission of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Rheumatic manifestations of psoriasis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Psoriatic nails: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients--an analysis of 1019 HLA-C- and HLA-B-typed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

A nail psoriasis severity index

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Nail changes in psoriasis: a study of 167 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: long-term results from a phase 2/3 clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Interobserver reliability of the Nail Psoriasis Severity Index

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Scalp psoriasis, clinical presentations and therapeutic management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007633.PUB2

7 January 2021

10.1002/14651858.CD007633.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2502498

2502498

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference